Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Trial of Health at Work Workplace Health Intervention (H@W)

This study has been completed.
Sponsor:
Information provided by:
University of Liverpool
ClinicalTrials.gov Identifier:
NCT00858533
First received: March 9, 2009
Last updated: July 26, 2010
Last verified: January 2010
  Purpose

This pilot study will compare workplace health intervention delivered by advisors based in GP practices with normal GP care to assess the usefulness of the concept and its potential for wider use in a larger randomised controlled trial.


Condition Intervention
Workplace Health
Behavioral: Health at Work workplace health advice and support

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Health Services Research
Official Title: A Pilot Controlled Feasibility Trial of Early Health at Work Workplace Intervention

Further study details as provided by University of Liverpool:

Primary Outcome Measures:
  • Number of days off work through sickness absence after index consultation, which will also apply to people at work with a work-relevant condition [ Time Frame: 1 year ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Secondary outcome measure: time to first return to work (RTW) allowing for phased return. [ Time Frame: 1 year ] [ Designated as safety issue: No ]

Enrollment: 63
Study Start Date: June 2008
Study Completion Date: March 2010
Primary Completion Date: March 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
workplace health advice
The intervention group will receive additional support from a H@W Workplace Health Advisor who will deliver an intervention aimed at sickness absence prevention or sustained return to work, depending on individual circumstances.
Behavioral: Health at Work workplace health advice and support
The intervention group will receive additional support from a H@W Workplace Health Advisor who will deliver an intervention aimed at sickness absence prevention or sustained return to work, depending on individual circumstances. The intervention will be standardized as far as possible to show types of activity undertaken with participants, their GP, line managers, human resources departments and trade union representatives.
No Intervention: GP sickness absence consultation
Routine general practitioner care for workplace sickness absence.
Behavioral: Health at Work workplace health advice and support
The intervention group will receive additional support from a H@W Workplace Health Advisor who will deliver an intervention aimed at sickness absence prevention or sustained return to work, depending on individual circumstances. The intervention will be standardized as far as possible to show types of activity undertaken with participants, their GP, line managers, human resources departments and trade union representatives.

Detailed Description:

The aim of this pilot study is to examine the impact of H@W intervention(s) on job retention and return to work and compare outcomes with those from normal GP care. The target population for this study is people still at work but experiencing a work-related health problem as well as those off work. For the purpose of the study, short term sickness absence is defined as a period of 4 weeks or less and long term sickness absence defined as a period of 4 weeks or longer. Hypothesis

That H@W intervention in comparison to standard care:

  • promotes work retention
  • enables a quick and sustained return to work for those on short term sick leave (4 weeks or less)
  • achieves sustained return to work for those on long term sick leave of 4 weeks or more. This could include a phased return to work.
  • achieves positive outcomes which could mean leaving one job and starting another.
  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • People with work related health problems registered with GP practices in Liverpool Primary Care Trust.

Exclusion Criteria:

  • People registered with GP practices outside Liverpool Primary Care Trust.
  • Vulnerable adults and those considered by their GP to be unsuitable for the trial.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00858533

Locations
United Kingdom
Division of Primary Care, University of Liverpool.
Liverpool, Merseyside, United Kingdom, L69 3GB
Sponsors and Collaborators
University of Liverpool
Investigators
Principal Investigator: Mark B Gabbay, MD University of Liverpool
  More Information

No publications provided

Responsible Party: Professor Mark Gabbay, University of Liverpool
ClinicalTrials.gov Identifier: NCT00858533     History of Changes
Other Study ID Numbers: BER10457
Study First Received: March 9, 2009
Last Updated: July 26, 2010
Health Authority: United Kingdom: National Health Service

Keywords provided by University of Liverpool:
early intervention
sickness absence
return to work
primary care

ClinicalTrials.gov processed this record on November 20, 2014